Derek J. Maetzold - Pres. & Chief Exec. Officer, Director at Castle Biosciences Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. & Chief Exec. Officer, Director
Stock Symbol
CSTL on Nasdaq
Industry
Services-Medical Laboratories
All Insider Reports
All Insider Reports

Derek J. Maetzold - trading volume in the past year for Castle Biosciences Inc

Holdings reported by Derek J. Maetzold for Castle Biosciences Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 123K $4.2M $34.15 Nov 12, 2024 By DJM Grantor Retained Annuity Trust No. 5
Common Stock 87.7K $3M $34.15 Nov 12, 2024 Direct
Restricted Stock Units 124K $2.66M $21.41 Mar 4, 2024 Direct Common Stock
Common Stock 74.6K $2.55M $34.15 Nov 12, 2024 By The Maetzold Descendants 2020 Trust
Common Stock 63.9K $2.18M $34.15 Nov 12, 2024 By Derek Maetzold 2020 Irrevocable Trust
Performance-Based Stock Unit 67K $1.8M $26.83 Aug 9, 2024 Direct Common Stock
Common Stock 26.1K $892K $34.15 Nov 12, 2024 By DJM Grantor Retained Annuity Trust No. 6
Common Stock 6.16K $210K $34.15 Nov 12, 2024 By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk
Common Stock 6.15K $210K $34.15 Nov 12, 2024 By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold
Common Stock 6.15K $210K $34.15 Nov 12, 2024 By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold
Common Stock 6.15K $210K $34.15 Nov 12, 2024 By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold
Stock option (right to buy) 0 $0 $3.72 Mar 5, 2024 Direct Common Stock

Transactions reported by Derek J. Maetzold for Castle Biosciences Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.